Details for 2019824223

Up to date per 01.04.2026

Actions

Title / Product Name

VERFAHREN ZUR DOSIERUNG UND BEHANDLUNG VON B-ZELL-MALIGNOMEN IN DER ADOPTIVEN ZELLTHERAPIE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019824223

EP Publication Number

3886894

E-Number

1665784

Language

PCT Number

US19063883

Publication Date

06.10.2021 A

13.03.2024 B1

Registration Date

13.03.2024

AT Publication Date

15.04.2024

Application Date

29.11.2019

Registration Number

Priorities

30.11.2018

201862774168 P

03.12.2018

201862774858 P

14.05.2019

201962847897 P

30.05.2019

201962854957 P

05.11.2019

201962931143 P

IPC

C12N 5/0783 20100101AFI20230914BHEP

Maximum Duration of Protection

29.11.2039

Owner

Juno Therapeutics, Inc.400 Dexter Ave. N Suite 1200 Seattle, WA 98109-4703US

Representative

Patentanwalt Mikšovsky KGBisamberger Straße 192100 KorneuburgAT

Inventor

GILLENWATER, Heidic/o Juno Therapeutics, Inc. 400 Dexter Ave. N Suite 1200 Seattle, Washington 98109-4703US

ALBERTSON, Tina400 Dexter Ave. N Suite 1200 Seattle, Washington 98109US

DUBOVSKY, Jason A.400 Dexter Ave. N Suite 1200 Seattle, Washington 98109US

THORPE, Jerill400 Dexter Ave. N Suite 1200 Seattle, Washington 98109US

Information about Fees